MedPath
Found 1715 clinical trials|View Analysis
Sort by:

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

Not Applicable
Not yet recruiting
Conditions
Glioblastoma
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
Central Hospital, Nancy, France
Target Recruit Count
18
Registration Number
NCT06764537
Locations
🇫🇷

Cell Therapy Unit, Nancy Hospital, Vandoeuvre-lès-Nancy, France

Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

Early Phase 1
Recruiting
Conditions
Glioblastoma (GBM)
Interventions
Drug: NRG-103
First Posted Date
2025-01-03
Last Posted Date
2025-01-03
Lead Sponsor
Zhongnan Hospital
Target Recruit Count
15
Registration Number
NCT06757153
Locations
🇨🇳

Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma

Phase 3
Not yet recruiting
Conditions
Glioblastoma
Interventions
Biological: Dendritic Cell Vaccine
Combination Product: Pembrolizumab
Other: Placebo
First Posted Date
2024-12-27
Last Posted Date
2024-12-27
Lead Sponsor
University of Sao Paulo General Hospital
Target Recruit Count
186
Registration Number
NCT06749925

Hypofractionated Radiotherapy

Not Applicable
Recruiting
Conditions
Glioblastoma
First Posted Date
2024-12-18
Last Posted Date
2024-12-18
Lead Sponsor
The First Hospital of Jilin University
Target Recruit Count
420
Registration Number
NCT06740955
Locations
🇨🇳

The First Hospital of Jilin University, Changchun, Jilin, China

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

Not Applicable
Not yet recruiting
Conditions
Glioblastoma
Radiotherapy Side Effect
First Posted Date
2024-12-05
Last Posted Date
2024-12-05
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Target Recruit Count
347
Registration Number
NCT06719440

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Not yet recruiting
Conditions
Brest Cancer
Lung Cancer (NSCLC)
Pancreatic Cancer, Adult
Prostate Cancers
Ovarian Cancer
Colorectal Cancer
Glioblastoma (GBM)
Liver Carcinoma
First Posted Date
2024-12-05
Last Posted Date
2024-12-13
Lead Sponsor
Javier Toledo
Target Recruit Count
6000
Registration Number
NCT06717295
Locations
🇦🇷

Various Cancer Centres, Rosario, Argentina

🇳🇬

NSIA- Lagos University Teaching Hospital Cancer Centre, Lagos, Nigeria

🇬🇧

Dysplasia Diagnostics Limited, London, United Kingdom

Impact of Salovum® and SPC Flakes on Brain Tumor Induced Edema

Phase 2
Not yet recruiting
Conditions
Glioblastoma
Cerebral Metastases
Meningioma
First Posted Date
2024-11-28
Last Posted Date
2024-11-28
Lead Sponsor
Peter Siesjö
Target Recruit Count
20
Registration Number
NCT06710249

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

Phase 1
Conditions
Glioblastoma (GBM)
Head and Neck Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Esophageal Cancer
First Posted Date
2024-11-15
Last Posted Date
2024-11-19
Lead Sponsor
Man Hu
Target Recruit Count
20
Registration Number
NCT06690216
Locations
🇨🇳

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China

WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients

Early Phase 1
Not yet recruiting
Conditions
Recurrent or Progressive Glioblastoma
First Posted Date
2024-11-15
Last Posted Date
2024-11-18
Lead Sponsor
Beijing Immunochina Medical Science & Technology Co., Ltd.
Target Recruit Count
6
Registration Number
NCT06691308

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Phase 2
Recruiting
Conditions
Glioma Glioblastoma Multiforme
High Grade Glioma (III or IV)
Interventions
Biological: NK cell therapy
First Posted Date
2024-11-13
Last Posted Date
2024-11-26
Lead Sponsor
Marzieh Ebrahimi
Target Recruit Count
40
Registration Number
NCT06687681
Locations
🇮🇷

Rasoul Akram hospital, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath